SYNTOCINON (oxytocin) by Novartis is clinical pharmacology oxytocin injection (synthetic) acts on the smooth muscle of the uterus to stimulate contractions; response depends on the uterine threshold of excitability.
Drug data last refreshed 22h ago · AI intelligence enriched 1mo ago
SYNTOCINON is a synthetic oxytocin injection administered via nasal route in solution form, indicated for stimulating uterine contractions during labor and delivery. It acts selectively on uterine smooth muscle to increase contraction frequency and tone, particularly toward the end of pregnancy and immediately post-delivery. Unlike natural posterior pituitary extracts, synthetic oxytocin lacks vasopressor effects on blood pressure.
Pre-launch stage with 16 linked positions suggests rapid team expansion in anticipation of market entry; strong opportunity for early career impact in commercial and clinical roles.
CLINICAL PHARMACOLOGY Oxytocin injection (synthetic) acts on the smooth muscle of the uterus to stimulate contractions; response depends on the uterine threshold of excitability. It exerts a selective action on the smooth musculature of the uterus, particularly toward the end of pregnancy, during…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Worked on SYNTOCINON at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Novartis is hiring 4 roles related to this product
With 16 linked positions across commercial, clinical, R&D, and supply chain functions, SYNTOCINON pre-launch phase offers entry and mid-level career opportunities to build products from market entry. Cross-functional experience during launch ramp will accelerate leadership pipeline development.
16 open roles linked to this drug